12/14/15 Konrad Hochedlinger, HSCI Principal Faculty member, identified a gene that when suppressed helps cells lose their "memory," making them more susceptible to reprogramming into iPS cells.
11/23/15 The Boston Globe photographs HSCI co-founder and co-director Doug Melton at the Joslin Diabetes Center's16th annual High Hopes Gala. Melton received a Global Achievement Award that night.
11/19/15 HSCI co-founder and co-director David Scadden speaks with CBS Chicago about the lack of scientific evidence and literature backing stem cell clinics and treatment centers.
11/19/15 Boston Business Journal publishes a Q&A with HSCI co-founder and co-director Doug Melton, who received a Global Achievement Award from Joslin Diabetes Center in recognition of his contributions to the field of diabetes research.
10/01/15 In The Scientist, an article exploring adult humans' ability to generate new neurons features the work of HSCI Principal Faculty Amar Sahay.
09/22/15 BBC News references HSCI Principal Faculty Member Harald Ott's work in an article about kidney regeneration.
09/18/15 An article in the Boston Globe pictures HSCI Executive Director Brock Reeve, who sat on a panel about gene and cell therapies at the BioPharma America conference.
09/02/15 An article published in the September issue of Discover Magazine features the work of HSCI Principal Faculty member Khalid Shah.
09/02/15 A Fox News article about stem cell tourism references a paper written and a panel organized by the Harvard Stem Cell Institute in 2013.
08/12/15 Healthline News interviewed HSCI Principal Faculty member Jeff Karp about a hydrogel he invented that targets inflamed tissue and delivers drugs for those with inflammatory bowel disease.
08/03/15 HSCI Principal Faculty member Olivier Pourquie's work generating muscle fibers to study muscular dystrophy is featured in Medical Daily.
07/31/15 An article in The Scientist features the work of HSCI Affiliated Faculty member Luk Vandenberghe, who resurrected the structure of ancient viruses to help improve gene therapy.
04/20/15 HSCI Affiliated Faculty member Xiaoliang Sunney Xie is awarded the $500,000 Albany Medical Center Prize in Biomedicine and Biomedical Research. Xie shares the prize with Standford University's Karl Deisseroth.
03/24/15 The Boston Globe features Semma Therapeutics, a new biotech company commercializing research from HSCI Co-founder and Principal Faculty member Doug Melton's lab. The company has raised $44 million to begin developing insulin-secreting cell transplant therapies for patients with Type 1 diabetes.
03/13/15 A Science news feature about eye transplants mentions HSCI Principal Faculty member Zhigang He's work on optic nerve regeneration.
02/26/15 In The Scientist, the latest work in the lab of HSCI Principal Faculty Jeff Karp (Brigham and Women's Hospital/Harvard Medical School) has important implications for improving the efficacy of mesenchymal stem cells (MSCs) used in clinical trials.
01/21/15 A Nature news feature on efforts to apply the findings of parabiotic research on mice to humans features HSCI Principal Faculty member Amy Wagers.